BlackRock Investment Management, LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 163 filers reported holding ANI PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$2,537,000
+10.4%
41,857
+20.8%
0.00%0.0%
Q3 2016$2,298,000
+23.0%
34,638
+3.5%
0.00%
+50.0%
Q2 2016$1,869,000
+75.3%
33,474
+5.7%
0.00%
+100.0%
Q1 2016$1,066,000
-25.2%
31,676
+0.3%
0.00%
-50.0%
Q4 2015$1,425,000
+15.8%
31,574
+1.3%
0.00%0.0%
Q3 2015$1,231,000
-37.4%
31,160
-1.6%
0.00%0.0%
Q2 2015$1,966,000
+28.1%
31,677
+29.1%
0.00%0.0%
Q1 2015$1,535,000
+38.5%
24,539
+24.9%
0.00%
+100.0%
Q4 2014$1,108,000
+95.8%
19,648
-1.8%
0.00%0.0%
Q3 2014$566,000
-16.9%
20,001
+1.2%
0.00%0.0%
Q2 2014$681,00019,7670.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders